Changes in visceral adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity

Obesity

Volumn 21, Issue 9, 2013, Pages

  Reimer, Raylene A ^a   Yamaguchi, Hideyo ^b   Eller, Lindsay K ^a   Lyon, Michael R ^c,d   Gahler, Roland J ^e   Kacinik, Veronica ^c   Juneja, Prateek ^c,d   Wood, Simon ^d,f  

^a UNIVERSITY OF CALGARY   (Canada)

^b TEIKYO UNIVERSITY   (Japan)

^c Canadian Centre for Functional Medicine   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Factors Group of Nutritional Studies Inc R 1 D   (Canada)

^f InovoBiologic Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCHOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; POLYGLYCOPLEX; POLYSACCHARIDE; RESISTIN; SHORT CHAIN FATTY ACID; TAUROCHOLIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COMMON COLD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, LDL; DIETARY FIBER; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; POLYSACCHARIDES; RESISTIN; SEX FACTORS; VISCOSITY; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84884907131     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20435     Document Type: Article

References (39)

1. Lattimer JM, Haub MD,. Effects of dietary fiber and its components on metabolic health. Nutrients 2010; 2: 1266-1289.
2. Raninen K, Lappi J, Mykkanen H, et al. Dietary fiber type reflects physiological functionality: comparison of grain fiber, inulin, and polydextrose. Nutr Rev 2011; 69: 9-21.
3. Anderson JW, Baird P, Davis Jr. RH, et al. Health benefits of dietary fiber. Nutr Rev 2009; 67: 188-205.
4. Karhunen LJ, Juvonen KR, Huotari A, et al. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept 2008; 149: 70-78.
5. Aleixandre A, Miguel M,. Dietary fiber in the prevention and treatment of metabolic syndrome: a review. Crit Rev Food Sci Nutr 2008; 48: 905-912.
6. Macfarlane GT, Macfarlane S,. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 2011;45 (Suppl): S120-S127.
7. Gunness P, Gidley MJ,. Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food Funct 2010; 1: 149-155.
8. Abdelhameed AS, Ang A, Morris GA, et al. An analytical ultracentrifuge study on ternary mixtures of konjac glucomannan supplemented with sodium alginate and xanthan gum. Carbohydr Polym 2010; 81: 145-148.
9. Harding SE, Smith IH, Lawson CJ, et al. Studies on macromolecular interactions in ternary mixtures of konjac glucomannan, xanthan gum and sodium alginate. Carbohydr Polym 2011; 83: 329-338.
10. ® in healthy adults. Eur J Clin Nutr 2010; 64: 1186-1191.
11. Brand-Miller JC, Atkinson FS, Gahler RJ, et al. Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia. Eur J Clin Nutr 2010; 64: 1488-1493.
12. ®, a novel functional fibre, on the glycaemic index of starchy foods. Br J Nutr 2012; 108: 245-248.
13. ®) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic rats. Life Sci 2011; 88: 392-399.
14. Reimer RA, Grover GJ, Koetzner L, et al. The soluble fiber complex PolyGlycopleX lowers serum triglycerides and reduces hepatic steatosis in high-sucrose-fed rats. Nutr Res 2011; 31: 296-301.
15. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
16. Kishida K, Funahashi T, Matsuzawa Y, et al. Visceral adiposity as a target for the management of the metabolic syndrome. Ann Med 2012; 44: 233-241.
17. Kishida K, Funahashi T, Shimomura I,. Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective. Curr Diabetes Rev 2012; 8: 84-91.
18. Pettinella C, Lee SH, Cipollone F, et al. Targeted quantitative analysis of fatty acids in atherosclerotic plaques by high sensitivity liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 850: 168-176.
19. Bobeldijk I, Hekman M, de Vries-van der Weij J, et al. Quantitative profiling of bile acids in biofluids and tissues based on accurate mass high resolution LC-FT-MS: compound class targeting in a metabolomics workflow. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 871: 306-313.
20. Grover GJ, Koetzner L, Wicks J, et al. Effects of the soluble fiber complex PolyGlycopleX on glucose homeostasis and body weight in young zucker diabetic rats. Front Pharmacol 2011; 2: 47.
21. Lyon MR, Reichert RG,. The effect of a novel viscous polysaccharide along with lifestyle changes on short-term weight loss and associated risk factors in overweight and obese adults: an observational retrospective clinical program analysis. Alternative Med Rev 2010; 15: 68-75.
22. Jenkins AL, Kacinik V, Lyon MR, et al. Reduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of good form. J Am Coll Nutr 2010; 29: 92-98.
23. ® is well tolerated by healthy subjects in a clinical trial. Nutr J 2009; 8: 1-11.
24. Reimer RA, Grover GJ, Koetzner L, et al. Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats. J Nutr 2012; 142: 1812-1820.
25. Paxman JR, Richardson JC, Dettmar PW, et al. Daily ingestion of alginate reduces energy intake in free-living subjects. Appetite 2008; 51: 713-719.
26. Chen HL, Sheu WH, Tai TS, et al. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects-a randomized double-blind trial. J Am Coll Nutr 2003; 22: 36-42.
27. Kirby RW, Anderson JW, Sieling B, et al. Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 1981; 34: 824-829.
28. Wright RS, Anderson JW, Bridges SR,. Propionate inhibits hepatocyte lipid synthesis. Proc Soc Exp Biol Med 1990; 195: 26-29.
29. Vogt JA, Wolever TM,. Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J Nutr 2003; 133: 3145-3148.
30. Reimer RA, Pelletier X, Carabin IG, et al. Faecal short chain fatty acids in healthy subjects participating in a randomised controlled trial examining a soluble highly viscous polysaccharide versus control. J Hum Nutr Diet 2012; 25: 373-377.
31. Rodbard HW, Bays HE, Gavin JR III, et al. Rate and risk predictors for development of self-reported type-2 diabetes mellitus over a 5-year period: the SHIELD study. Int J Clin Pract 2012; 66: 684-691.
32. Robertson MD, Wright JW, Loizon E, et al. Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome. J Clin Endocrinol Metab 2012; 97: 3326-3332.
33. ®, to commonly consumed foods on glycemic response, glycemic index and GRIP: a simple and effective strategy for reducing post prandial blood glucose levels-a randomized, controlled trial. Nutr J 2010; 9: 58.
34. Wolever TM, Jenkins DJ, Ocana AM, et al. Second-meal effect: low-glycemic-index foods eaten at dinner improve subsequent breakfast glycemic response. Am J Clin Nutr 1988; 48: 1041-1047.
35. Nilsson A, Ostman E, Preston T, et al. Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr 2008; 62: 712-720.
36. Fujioka S, Matsuzawa Y, Tokunaga K, et al. Improvement of glucose and lipid metabolism associated with selective reduction of intraabdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 1991; 15: 853-859.
37. Ma K, Jin X, Liang X, et al. Inflammatory mediators involved in the progression of metabolic syndrome. Diabetes Metab Res Rev 2012; 28: 388-394.
38. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
39. Lagathu C, Bastard JP, Auclair M, et al. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003; 311: 372-379.